The Lockwood Group announced the acquisition of Research To Practice (RTP), a leading provider of accredited oncology-focused medical education for healthcare professionals. This strategic move enhances The Lockwood Group’s position as a global healthcare services platform with expertise across medical communications, education, animation and visualization, regulatory and clinical consulting, and market access.
Based in Stamford, Connecticut, The Lockwood Group stated that the acquisition represents a significant advancement in its mission to empower clinicians with evidence-based insights that improve patient outcomes. With the addition of RTP’s specialized oncology programs, the combined organization aims to broaden its global impact on continuing medical education and strengthen its ability to deliver science-driven learning experiences for healthcare professionals worldwide.
Founded by medical oncologist Dr. Neil Love, Research To Practice has been a pioneer in oncology education for over four decades. The company produces high-impact, accredited activities that help clinicians remain informed in an ever-evolving cancer treatment landscape. Its programming spans live symposia, regional and local meetings, podcasts, webinars, multimedia roundtables, and interactive events, all designed to address real-world clinical challenges through the perspectives of leading experts.
The partnership brings together two organizations recognized for their deep scientific expertise and commitment to advancing knowledge across healthcare disciplines. Together, The Lockwood Group and RTP will continue developing innovative educational formats that expand access to trusted, evidence-based resources for clinicians, researchers, and patients worldwide.
KEY QUOTES:
“We are thrilled to welcome Research To Practice to The Lockwood Group. RTP’s deep expertise in oncology, their trusted relationships with clinical thought leaders, and their legacy of delivering best-in-class continuing education align seamlessly with The Lockwood Group’s science-first, insight-driven approach. Together, we will expand our collective reach and continue delivering impactful education that improves patient care worldwide.”
Matthew Schecter, Founder & CEO, The Lockwood Group
“Joining The Lockwood Group provides us the opportunity to further advance our mission of improving cancer care through education. Their strategic insight and global capabilities will help us further elevate and expand the ways we connect with and support the diverse needs of oncology clinicians.”
Neil Love, MD, Founder, Research To Practice
